TCL Archive Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study May 30, 2008
TCL Archive Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million January 19, 1979